ADAR1 Capital Management »

Calcimedica shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Calcimedica (CALC) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Calcimedica

Tip: Access up to 7 years of quarterly data

All positions including Calcimedica held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calcimedica by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2k 781 4.16

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Calcimedica

Deerfield Management Company
Soleus Capital Management
Aisling Capital Management
Vanguard Group
BML Capital Management
Millennium Management
Meritage Portfolio Management
Geode Capital Management
Envestnet Asset Management
J. Goldman & Co
Tritonpoint Wealth
BlackRock
First Manhattan
Atria Investments
Bank of America Corporation

View all funds holding Calcimedica